Clinical and Economic Burden of Patients With Severe Asthma Untreated With a Biologic in the United States, Overall and by Blood Eosinophil and Level of Asthma Control

被引:0
|
作者
Kilpatrick, Karynsa [1 ]
Jo, Heejoo [1 ]
Desai, Pooja [2 ]
Ackert, Jean-Pierre Llanos [3 ]
Rane, Pallavi [2 ]
Ambrose, Chris [4 ]
Chung, Yen [5 ]
Oppenheimer, John [6 ]
Goldstein, Stanley [7 ]
机构
[1] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA USA
[2] Amgen Inc, Hlth Econ & Outcomes Res, Thousand Oaks, CA USA
[3] Amgen Inc, Global Med Affairs, Thousand Oaks, CA USA
[4] AstraZeneca, Biopharmaceut Med, Resp & Immunol, Gaithersburg, MD USA
[5] AstraZeneca, Payer Evidence, Gaithersburg, MD USA
[6] Pulm & Alergy Associates, E Hanover, NJ USA
[7] Allergy & Asthma Care Long Isl, New York, NY USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
053
引用
收藏
页码:AB19 / AB19
页数:1
相关论文
共 50 条
  • [41] Effect Of Mepolizumab On Health Status, Lung Function And Asthma Control According To Baseline Blood Eosinophil Count In Patients With Severe Eosinophilic Asthma
    Trevor, J. L.
    Albers, F. C.
    Nelsen, L. M.
    Bratton, D. J.
    Wang-Jairaj, J.
    Bradford, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [42] Clinical characteristics and burden of illness in a cohort of severe asthma patients
    Muellerova, Hana
    Gunsoy, Necdet
    Cockle, Sarah
    Nelsen, Linda
    Albers, Frank
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [43] Severe asthma exacerbations in the United States: Incidence, characteristics, predictors, and effects of biologic treatments
    Trevor, Jennifer
    Lugogo, Njira
    Carr, Warner
    Moore, Wendy C.
    Soong, Weily
    Panettieri, Reynold A. Jr Jr
    Desai, Pooja
    Trudo, Frank
    Ambrose, Christopher S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : 579 - +
  • [44] The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence
    Perry, Richard
    Braileanu, George
    Palmer, Thomas
    Stevens, Paul
    PHARMACOECONOMICS, 2019, 37 (02) : 155 - 167
  • [45] The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence
    Richard Perry
    George Braileanu
    Thomas Palmer
    Paul Stevens
    PharmacoEconomics, 2019, 37 : 155 - 167
  • [46] Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies
    Hansen, Susanne
    Sondergaard, Marianne Baastrup
    von Bulow, Anna
    Bjerrum, Anne-Sofie
    Schmid, Johannes
    Rasmussen, Linda M.
    Johnsen, Claus R.
    Ingebrigtsen, Truls
    Hakansson, Kjell Erik Julius
    Johansson, Sofie Lock
    Bisgaard, Maria
    Assing, Karin Dahl
    Hilberg, Ole
    Ulrik, Charlotte
    Porsbjerg, Celeste
    CHEST, 2024, 165 (02) : 253 - 266
  • [47] Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
    Ortega, Hector
    Katz, Lynn
    Hartley, Benjamin
    Yancey, Steve
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [48] Analysis of the relationship between FeNO and blood eosinophil count in severe asthma patients
    O'Hanlon, James
    Mainra, Amar
    Long, Deirdre
    Lombard, Lorna
    MacHale, Elaine
    Ryan, Dorothy
    Costello, Richard
    Cushen, Breda
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S137 - S137
  • [49] High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma
    Fowler, Stephen J.
    Tavernier, Gael
    Niven, Robert
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (03) : 822 - 824
  • [50] Blood Eosinophil Phenotype During Treatment With Mepolizumab in Patients With Severe Eosinophilic Asthma
    Sakai, C.
    Matsuyama, M.
    Nakajima, M.
    Matsumura, S.
    Nonaka, M.
    Arai, N.
    Kuramoto, K.
    Yoshida, K.
    Morishima, Y.
    Muratani, M.
    Hizawa, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209